Theralink® Technologies Achieves the First College of American Pathologists Accreditation for a Commercial Reverse Phase Protein Array Laboratory in U.S.

College of American Pathologists (CAP) Accreditation Signifies the Highest Standards in Laboratory Practice GOLDEN, Colo., Nov. 28, 2022 /PRNewswire/ — Theralink Technologies (OTC: THER) (“Theralink” or the “Company”), a precision oncology company with a novel phosphoprotein-based assay…

Click here to view original post